Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent or refractory lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Lymphoma
• Aids-related Primary Cns Lymphoma
• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• Lymphoblastic Lymphoma
• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma | Phase 1 | Status: TERMINATED